| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 124.981 | 61.310 | 37.058 | 82.589 | 50.178 | 62.578 | 38.158 | 184.334 | 323.932 | 348.470 |
| Total Income - EUR | 124.986 | 61.310 | 48.592 | 93.683 | 50.406 | 64.090 | 43.411 | 184.539 | 323.932 | 358.974 |
| Total Expenses - EUR | 92.130 | 79.245 | 25.238 | 40.712 | 58.465 | 55.575 | 37.383 | 159.057 | 222.434 | 176.868 |
| Gross Profit/Loss - EUR | 32.856 | -17.934 | 23.354 | 52.970 | -8.059 | 8.515 | 6.028 | 25.482 | 101.498 | 182.106 |
| Net Profit/Loss - EUR | 32.856 | -17.934 | 20.565 | 52.932 | -8.059 | 8.515 | 6.028 | 22.408 | 85.185 | 152.871 |
| Employees | 14 | 13 | 10 | 7 | 0 | 7 | 8 | 9 | 2 | 2 |
Check the financial reports for the company - Aldraxim Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 50.376 | 47.093 | 46.249 | 46.054 | 44.871 | 43.735 | 42.614 | 42.746 | 42.617 | 69.165 |
| Current Assets | 132.431 | 131.472 | 112.388 | 98.966 | 82.889 | 118.079 | 151.043 | 201.034 | 210.538 | 188.237 |
| Inventories | 23.092 | 21.478 | 18.672 | 18.034 | 15.404 | 18.418 | 18.409 | 17.026 | 11.801 | 1.904 |
| Receivables | 109.010 | 109.409 | 93.530 | 80.956 | 67.336 | 98.671 | 129.643 | 181.588 | 163.086 | 143.865 |
| Cash | 329 | 586 | 186 | -24 | 149 | 990 | 2.990 | 2.420 | 35.651 | 42.468 |
| Shareholders Funds | -294.061 | -308.997 | -283.203 | -225.074 | -229.433 | -216.568 | -205.737 | -183.968 | -98.224 | 55.196 |
| Social Capital | 114.511 | 113.343 | 111.425 | 109.380 | 107.262 | 105.228 | 102.895 | 103.214 | 102.901 | 102.326 |
| Debts | 476.869 | 487.562 | 441.839 | 370.094 | 357.192 | 378.382 | 399.394 | 427.748 | 351.380 | 202.747 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4211 - 4211" | |||||||||
| CAEN Financial Year |
4120
|
|||||||||
Comments - Aldraxim Srl